What’s New and Updates/Changes

US FDA Approval of Ledipasvir/Sofosbuvir
Monday, November 3, 2014

The panel is meeting and currently reviewing data to update the Guidance based on the US FDA approval of ledipasvir/sofosbuvir. The updated Guidance will be posted in early December.

Updated Introductory Statement of When and In Whom to Initiate Therapy
Thursday, October 23, 2014

The introductory statement of When and In Whom to Initiate Therapy has been revised to reiterate that treatment will benefit almost all patients in all stages of chronic infection and that urgent initiation of therapy is needed in patients with certain conditions.

New Section: Management of Acute HCV Infection
Wednesday, October 8, 2014

The newest section of the AASLD/IDSA/IAS–USA hepatitis C Guidance, Management of Acute HCV Infection, is now available. Click here to access this section.

Updated Information on Drug Interactions
Friday, September 26, 2014

Updated information on drug interactions between simeprevir and certain immunosuppressant drugs has been added based on the manufacturer's revised product prescribing information. For more information see Unique Patient Populations.

New Section: Monitoring Patients Who Are Starting HCV Treatment, Are On Treatment, Or Have Completed Therapy
Wednesday, September 24, 2014

The newest section of the AASLD/IDSA/IAS-USA hepatitis C Guidance, Monitoring Patients Who Are Starting HCV Treatment, Are On Treatment, Or Have Completed Therapy, is now available. Click here to access this section.

Pages